| Size | 100 mL/500 mL |
| Advantages | This hepatoblastoma organoid kit precisely models the tumor's 3D structure and microenvironment. It offers a stable in vitro platform for studying tumor cell dynamics and drug responses, making it ideal for evaluating anticancer agent efficacy and toxicity in personalized medicine and drug screening. |
| Components | Basal Medium A; Supplement B & Supplement C. |
| Research Areas | Drug discovery and toxicity testing; Disease modeling |
| Applications | Organoid culture |
| Storage | Basal Medium A: 4°C, 1 year; Supplement B & Supplement C: -20°C, 1 year. |
| Shipping Information | Basal Medium A: Shipping with blue ice Supplement B & Supplement C: Shipping with dry ice. |
| Notes | Refrain from subjecting the product to multiple freeze-thaw cycles. |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.